Several studies have investigated potential early AKI biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL), Cystatin C, interleukin-18, renal injury molecule-1 (KIM-1), and others [6,7,8,9,10]. The gene discussed is LCN2; the disease is acute kidney injury.